Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Cooper

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1974
Von Willebrand factor: gene dosage relationships and transfusion response in bleeder swine--a new bioassayT R Griggs, W P Webster, H A Cooper, et al.
Circulation|September 24, 1999
Diuretics and risk of arrhythmic death in patients with left ventricular dysfunctionH A Cooper, D L Dries, C E Davis, et al.
Thrombosis and Haemostasis|December 8, 1998
Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgeryA D Shapiro, G S Gilchrist, W K Hoots, et al.
The American Journal of Cardiology|September 25, 1999
Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (studies of left ventricular dysfunction)H Rashid, D V Exner, I Mirsky, et al.
Journal of Pediatric Hematology/Oncology|August 13, 1999
Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer GroupW R Rackoff, J Ge, H N Sather, et al.
The Tohoku Journal of Experimental Medicine|October 1, 1987
Two affinity immunoelectrophoretic methods for studying collagen interaction with von Willebrand factor antigenM Aihara, I Kudo, H Ishigaki, et al.
The New England Journal of Medicine|February 25, 1999
Racial differences in the outcome of left ventricular dysfunctionD L Dries, D V Exner, B J Gersh, et al.
The Journal of Pediatrics|May 1, 1994
Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic conditionG R Jones, G K Konsler, R P Dunaway, et al.
Thrombosis Research|December 15, 1986
A paradoxical effect of antibody concentration on vWF-dependent platelet agglutination distinguishes between botrocetin and ristocetin-induced agglutinationD W Roberson, G R Upchurch, M A Lamb, et al.
Thrombosis and Haemostasis|April 30, 1986
Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complexM Aihara, Y Sawada, K Ueno, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1974
Von Willebrand factor: gene dosage relationships and transfusion response in bleeder swine--a new bioassayT R Griggs, W P Webster, H A Cooper, et al.
Circulation|September 24, 1999
Diuretics and risk of arrhythmic death in patients with left ventricular dysfunctionH A Cooper, D L Dries, C E Davis, et al.
Thrombosis and Haemostasis|December 8, 1998
Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgeryA D Shapiro, G S Gilchrist, W K Hoots, et al.
The American Journal of Cardiology|September 25, 1999
Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (studies of left ventricular dysfunction)H Rashid, D V Exner, I Mirsky, et al.
Journal of Pediatric Hematology/Oncology|August 13, 1999
Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer GroupW R Rackoff, J Ge, H N Sather, et al.
The Tohoku Journal of Experimental Medicine|October 1, 1987
Two affinity immunoelectrophoretic methods for studying collagen interaction with von Willebrand factor antigenM Aihara, I Kudo, H Ishigaki, et al.
The New England Journal of Medicine|February 25, 1999
Racial differences in the outcome of left ventricular dysfunctionD L Dries, D V Exner, B J Gersh, et al.
The Journal of Pediatrics|May 1, 1994
Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic conditionG R Jones, G K Konsler, R P Dunaway, et al.
Thrombosis Research|December 15, 1986
A paradoxical effect of antibody concentration on vWF-dependent platelet agglutination distinguishes between botrocetin and ristocetin-induced agglutinationD W Roberson, G R Upchurch, M A Lamb, et al.
Thrombosis and Haemostasis|April 30, 1986
Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complexM Aihara, Y Sawada, K Ueno, et al.
Pageof 6